Compare Stryker Corporation (SYK) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs Clear Secure Inc — how do they compare? Stryker Corporation trades at $277.33 (market cap $106.24B), while Clear Secure Inc trades at $43.43 (market cap $4.44B). The key difference: Stryker Corporation is far larger — about 23.9× Clear Secure Inc's market cap, and Clear Secure Inc pays the higher dividend (1.33%). Which is the better fit depends on your goals — on Pluang, investors hold Stryker Corporation for 21 Days and Clear Secure Inc for 19 Days on average.
| SYK | YOU | |
|---|---|---|
Market Cap | $106.24B | $4.44B |
Volume | 2,982,001 | 1,477,828 |
Sector | Health | Technology |
52-Week High | $388.35 | $62.36 |
52-Week Low | $269.75 | $29.61 |
Typical Hold Time | 21 Days | 19 Days |
Enterprise Value | $117.70B | $3.59B |
Dividend Yield | 1.27% | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.
The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.
Clear Secure (YOU) trades at $43.43, up 2.0% today, with a bullish technical signal despite overbought RSI readings. The company reported strong Q2 2026 results, beating EPS estimates with $0.49 versus $0.40 expected, and revenue growth accelerated to 27% year-over-year. Analyst consensus is mixed with a $61.40 price target, and the stock shows robust profitability with a 90.29% ROE and expanding margins.
The outlook is positive given membership growth and new enterprise initiatives, but risks include high valuation multiples and insider selling. The stock offers growth potential driven by identity platform expansion, though investors should weigh competitive pressures and execution risks against strong fundamental trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
